183741-80-2

Basic information

• Product Name: TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE
• Synonyms: TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE;(6-Methoxy-3-pyridinyl)-carbamic acid 1,1-dimethylethyl ester;tert-Butyl N-(6-methoxypyridin-3-yl)carbamate;(6-Methoxy-pyridin-3-yl)-carbaMic acid tert-butyl ester;tert-butyl 6-Methoxypyridin-3-ylcarbaMate;3-(Boc-amino)-6-methoxypyridine;tert-Butyl (6-methoxypyridin-3-yl)
• CAS NO: 183741-80-2
• Molecular Formula: C₁₁H₁₆N₂O₃
• Molecular Weight: 224.26
• Mol File: 183741-80-2.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 278.6℃
• Flash Point: 122.3℃
• Appearance: /
• Density: 1.146
• Vapor Pressure: 0.00422mmHg at 25°C
• Refractive Index: 1.534
• Storage Temp.: 2-8°C
• CAS DataBase Reference: TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE(183741-80-2)
• EPA Substance Registry System: TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE(183741-80-2)

Safety Data

• Hazardous Substances Data: 183741-80-2(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE is a chemical compound with the molecular formula C13H19N3O3. It is a carbamate derivative used as a pharmaceutical intermediate and in the synthesis of organic compounds. This chemical is typically used in the manufacturing of various drugs and agrochemicals. It has a tert-butyl group, a pyridyl group, and a methoxy group, making it useful in the development of novel medications and pesticides. TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE may also have application in the field of medicinal and agricultural chemistry due to its potential biological activities.

InChI:InChI=1/C11H16N2O3/c1-11(2,3)16-10(14)13-8-5-6-9(15-4)12-7-8/h5-7H,1-4H3,(H,13,14)

Upstream product

• 6628-77-9 6-methoxy-pyridin-3-ylamine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 183741-86-8 5-((tert-butoxycarbonyl)amino)-2-methoxyisonicotinic acid 
• 727993-76-2 5-methoxy-2,3-dihydro-1H-pyrrolo[2,3-c]pyridine-7-carbonitrile 
• 727993-74-0 tert-butyl 5-methoxy-2,3-dihydro-1H-pyrrolo[2,3-c]pyridine-1-carboxylate 
• 183741-91-5 5‐amino‐2‐methoxypyridine‐4‐carboxylic acid 
• 183741-98-2 6-methoxypyrido[3,4-d]pyrimidin-4(3H)-one 
• 1018812-95-7 tert-butyl N-(4-acetyl-6-methoxypyridin-3-yl)carbamate 
• 1201787-98-5 3-methoxy-6-pyrid-3-yl-9-(toluene-4-sulfonyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine 
• 1201787-99-6 3-methoxy-4-iodo-6-pyrid-3-yl-9-(toluene-4-sulfonyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine 
• 1454802-99-3 C₁₁H₁₈N₃O₃⁽¹⁺⁾*C₉H₁₁O₃S^(1-) 
• 952059-64-2 6-methoxy-1,7-naphthyridin-4(1H)-one 
• 952059-61-9 4-chloro-6-methoxy-1,7-naphthyridine 
• 1200130-06-8 6-methoxy-3-(4-(piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c′]dipyridine 
• 227180-21-4 4-iodo-6-methoxypyridin-3-ylamine 

Relevant articles and documents

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF

Disclosed herein are methods and compounds of augmenting and enhancing the production of type I IFNs in vivo. In some embodiments, the compounds disclosed herein are ENPP-1 inhibitors, pharmaceutical compositions, and methods for the treatment of cancer or a viral infection.

Discovery of a novel series of thienopyrimidine as highly potent and selective PI3K inhibitors

Inhibition of the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway provides a promising new approach for cancer therapy. Through a rational design, a novel series of thienopyrimidine was discovered as highly pote

AZACARBOLINE DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME

The invention relates to novel azacarbonlines having formula (I), wherein: R3, R4 represent independently H; hal; CF3; substituted oxy, optionally substituted alkoxy; optionally substituted amino; substituted carbonyl; optionally substituted carboxyl; optionally substituted amide; sulphur, such as optionally substituted sulphones, sulphoxides or sulphides; linear, branched or cyclic C1-C10 alkyl optionally comprising an optionally substituted heteroatom; optionally substituted linear, branched or cyclic C2-C7 alkenyl; optionally substituted linear or branched C2-C6 alkynyl; optionally substituted aryl or heteroaryl; of which may be optionally substituted; in the form of a base or an acid addition salt. The invention also relates to the use of same in therapeutics for the treatment of cancer and to synthesis methods.